Geometric Network Analysis Provides Prognostic Information in Patients with High Grade Serous Carcinoma of the Ovary Treated with Immune Checkpoint Inhibitors
R. Elkin, J. H. Oh, Y. L. Liu, P. Selenica, B. Weigelt, J. S. Reis-Filho, D. Zamarin, J. O. Deasy, L. Norton, A. J. Levine, A. R. Tannenbaum
Abstract
PurposeNetwork analysis methods can potentially quantify cancer disturbances in gene networks without introducing fitted parameters or variable selection. A new network curvature-based method is introduced to provide an integrated measure of variability within cancer gene networks. The method is applied to high grade serous ovarian cancers (HGSOCs) to predict response to immune checkpoint inhibitors (ICIs), and to rank key genes associated with prognosis. MethodsCopy number alterations (CNAs) from targeted and whole exome sequencing data were extracted for HGSOC patients (n = 45) treated with ICIs. CNAs at a gene level were represented on a protein-protein interaction network to define patient-specific networks with a fixed topology. A version of Ollivier-Ricci curvature was used to identify genes that play a potentially key role in response to immunotherapy and further to stratify patients at high risk of mortality. Overall survival (OS) was defined as the time from the start of ICI treatment to either death or last follow-up. Kaplan-Meier analysis with log-rank test was performed to assess OS between the high and low curvature classified groups. ResultsThe network curvature analysis stratified patients at high risk of mortality with p=0.00047 in Kaplan-Meier analysis. Genes with high curvature were in accordance with CNAs relevant to ovarian cancer. ConclusionNetwork curvature using CNAs has the potential to be a novel predictor for OS in HGSOC patients treated with immunotherapy.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-Omics Analysis Reveals the Attenuation of the Interferon Pathway as a Driver of Chemo-Refractory Ovarian Cancer
Daria Afenteva, Rong Yu, … Sampsa Hautaniemi·Cell Reports MedicinePeer-reviewed·Aug 29, 2025
- On the predictability of progression-free survival in ovarian cancer from NanoString gene expression data
Lucy B. Van Kleunen, Grace I. Bowman, … Aaron J. Clauset·bioRxiv·Apr 24, 2026
- CACNA1C as a Prognostic Biomarker and Therapeutic Target in High-Grade Serous Ovarian Cancer: Clinical Validation and Molecular Dynamics of Nifedipine Blockade
Mohamed Hammad, Kingsley Wu, … Chia‐en A. Chang·bioRxiv·Apr 22, 2026
- Multi-omic integrated curvature study on pan-cancer genomic data
Jiening Zhu, Anh Phong Tran, … Allen Tannenbaum·Mathematics of Control Signals and SystemsPeer-reviewed·Jul 12, 2023
- Gene networks and expression quantitative trait loci associated with platinum-based chemotherapy response in high-grade serous ovarian cancer
J. Choi, A. Tarnouskaya, … Q. Duan·bioRxiv·Nov 26, 2019
- Characterizing Cancer Drug Response and Biological Correlates: A Geometric Network Approach
M. Pouryahya, J. H. Oh, … A. R. Tannenbaum·bioRxiv·Nov 22, 2017